Anemia: Clinical Trials

50 trials for Anemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

50 terminated. 50 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable50Terminated 50

Follow Anemia: new trials by email Literature Review of Anemia trials Research Report on Anemia

Trials (filtered) newest first · largest first

All 50 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector
Gene-modified autologous stem cells - Fanconi Anemia
Not applicableTerminatedShenzhen Geno-Immune Medical Institute102026-06-012026-08-24
Alternate Day vs. Daily Iron Supplementation in Iron Depleted Women in the Philippines
daily ferrous sulfate, alternate day ferrous sulfate - Iron-deficiency
Not applicableTerminatedSwiss Federal Institute of Technology222022-04-062024-01-25
A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge
Red blood cell transfusion - Anemia, Red Blood Cell Transfusion
Not applicableTerminatedUniversity of Chicago232022-02-012025-04-01
COVID-19 Testing in Underserved and Vulnerable Populations
Community outreach method - Heart Failure, Coronary Artery Disease
Not applicableTerminatedJesse Nodora91202020-11-012024-02-28
Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment
off-the-shelf digital CBT, adapted digital CBT - Sickle Cell Disease, Depression
Not applicableTerminatedUniversity of Pittsburgh212020-08-122024-04-30
Use of Cast Iron Pots to Improve Maternal Anemia
Cast Iron Pot, Alumnium Pot - Iron-deficiency Anemia
Not applicableTerminatedWeill Medical College of Cornell University342020-07-152020-07-30
Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease
αβ+ T-cell depletion with Miltenyi CliniMACS system - Sickle Cell Disease
Not applicableTerminatedUniversity of Chicago32020-04-072024-12-04
Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study
Acupuncture - Sickle Cell Disease
Not applicableTerminatedUniversity of Illinois at Chicago62020-01-152022-04-12
The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis
Alixir 400 Protect - Renal Disease, Dialysis; Complications
Not applicableTerminatedUniversity of Kragujevac302019-08-012019-12-24
Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial
Anemia Control Model (ACM), IV iron, Erythropoiesis-Stimulating Agent (ESA) - Anemia, End Stage Renal Disease
Not applicableTerminatedVifor Fresenius Medical Care Renal Pharma882018-12-102020-01-07
Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
Part A Survey, Part B Yoga Program - Sickle Cell Disease
Not applicableTerminatedEmory University352018-11-082021-07-16
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
Training for use of web based Decision Aid, No training for use of web based Decision Aid, Pretest surveys and posttest surveys - Sickle Cell Disease
Not applicableTerminatedEmory University22018-08-032019-07-23
Sleep Apnea in Sickle Cell Disease
polysomnography and oxygen saturation exam, calculation of VOC frequency between the first polysomnography and the end of the first year of continuous positive airway pressure treatment, Blood samples - Sickle Cell Disease
Not applicableTerminatedHospices Civils de Lyon302018-05-282022-12-28
Erythropoietin Role in Acute Kidney Injury
Erythropoietin - Anemia Renal
Not applicableTerminatedSaint-Joseph University1342018-04-162021-12-28
Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE)
Mirasol Red Blood Cells (MIR RBCs), Reference Red Blood Cells (REF RBCs) - Transfusion Dependent Thalassemia
Not applicableTerminatedTerumo BCTbio92018-04-122024-02-14
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
Relaxation response and virtual reality (VR) session - Sickle Cell Disease, Virtual Reality
Not applicableTerminatedDuke University202018-02-052021-03-01
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Fludarabine, Cyclophosphamide, Total Body Irradiation - Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL)
Not applicableTerminatedMasonic Cancer Center, University of Minnesota2002016-12-012026-05-20
Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training
Iron Aid IPS (Iron Protein Succinylate), Sugar Pill - Iron-deficiency
Not applicableTerminatedUniversity of Mary Hardin-Baylor22016-11-292018-08-08
Oral Iron Substitution for Orthopedic Surgery
OLEOvital - Iron Deficiency Anemia
Not applicableTerminatedKepler University Hospital202016-11-252018-08-09
Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard
conventional ABG analyser, Proxima 3® - Hypoxia, Hypercapnia
Not applicableTerminatedUniversitair Ziekenhuis Brussel202016-09-012025-11-18

Showing 20 of 50. Sign in to see all of them.

Narrower conditions

Anemia, Sickle Cell (19)  ·  Leukemia, Myeloid, Acute (6)  ·  Lymphoma, Mantle-Cell (6)  ·  Lymphoma, Non-Hodgkin (6)  ·  Multiple Myeloma (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (6)  ·  Anemia, Iron-Deficiency (5)  ·  Anemia, Refractory, with Excess of Blasts (5)  ·  Hodgkin Disease (5)  ·  Leukemia (5)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (5)  ·  Lymphoma, Follicular (5)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Primary Myelofibrosis (5)

Broader conditions

Hemic and Lymphatic Diseases (50)  ·  Hematologic Diseases (49)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (26)  ·  Genetic Diseases, Inborn (23)  ·  Anemia, Hemolytic (21)  ·  Anemia, Hemolytic, Congenital (21)  ·  Hemoglobinopathies (20)  ·  Pathological Conditions, Signs and Symptoms (20)  ·  Metabolic Diseases (12)  ·  Nutritional and Metabolic Diseases (12)  ·  Pathologic Processes (12)  ·  Bone Marrow Diseases (11)  ·  Chronic Disease (10)  ·  Disease Attributes (10)

Interventions

Cyclophosphamide (7)  ·  Cyclosporine (4)  ·  fludarabine (4)  ·  fludarabine phosphate (4)  ·  Blood Specimen Collection (3)  ·  Busulfan (3)  ·  Mycophenolic Acid (3)  ·  Alemtuzumab (2)  ·  Blood Transfusion (2)  ·  Cord Blood Stem Cell Transplantation (2)  ·  Epoetin Alfa (2)  ·  Ferric Oxide, Saccharated (2)  ·  Mesna (2)  ·  Radiotherapy (2)  ·  Whole-Body Irradiation (2)

Sponsors

Emory University (3)  ·  Masonic Cancer Center, University of Minnesota (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  University of Chicago (2)  ·  Albert Einstein College of Medicine (1)  ·  Baylor College of Medicine (1)  ·  Billy Sin (1)  ·  Chinese University of Hong Kong (1)  ·  City of Hope Medical Center (1)  ·  Columbia University (1)  ·  DBL -Institute for Health Research and Development (1)  ·  Duke University (1)  ·  Haukeland University Hospital (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital Clinic of Barcelona (1)

Countries

United States (32)  ·  France (4)  ·  Belgium (2)  ·  China (2)  ·  Austria (1)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Lebanon (1)  ·  Norway (1)  ·  Philippines (1)  ·  Serbia (1)  ·  Spain (1)

Top investigators

Tami John, MD (2)  ·  Alan Tinmouth, MD, MSc (1)  ·  Anders Troelsen, PhD (1)  ·  Anita Mehrotra, MD (1)  ·  Aprille Seidel, PhD (1)  ·  Ashish Gupta, MBBS, MPH (1)  ·  Charles R Jonassaint, PhD (1)  ·  Christine Sneyers, Nurse (1)  ·  Claire Heilbronner, MD, PhD (1)  ·  Clara Menendez, MD, PhD (1)  ·  Claudio Brunstein, MD (1)  ·  Damien Pouessel, MD (1)  ·  Deepa Manwani, MD (1)  ·  Elena Carreras, PhD (1)  ·  Elena Martinez, PhD (1)

Results publications

PMID 38780066, PMID 26095669, PMID 28764674, PMID 33892094, PMID 34080441, PMID 34327604, PMID 34630163, PMID 34932828, PMID 35279078, PMID 36791280, PMID 37023443, PMID 38036166, PMID 9310602

NIH funding

1RC2HL101496 (1), 3UH3CA233314-02S1 (1), P30CA033572 (1), R01HL098014 (1), R34MH125152 (1)